5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | SELL | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.43▲ | 8.41▲ | 8.42▲ | 8.71▼ | 8.43▲ |
MA10 | 8.42▲ | 8.41▲ | 8.48▲ | 8.53▼ | 8.29▲ |
MA20 | 8.40▲ | 8.49▲ | 8.56▼ | 8.44▲ | 8.62▼ |
MA50 | 8.40▲ | 8.59▼ | 8.56▼ | 8.31▲ | 10.17▼ |
MA100 | 8.50▲ | 8.52▲ | 8.48▲ | 8.82▼ | 11.53▼ |
MA200 | 8.56▼ | 8.46▲ | 8.32▲ | 9.85▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.012▲ | 0.006▲ | -0.019▼ | 0.025▲ | 0.112▲ |
RSI | 76.266▲ | 52.793▲ | 48.549▼ | 51.897▲ | 45.275▼ |
STOCH | 55.556 | 37.896 | 18.690▼ | 66.442 | 36.591 |
WILL %R | 0.000▲ | -36.364 | -49.275 | -48.837 | -64.840 |
CCI | 350.722▲ | 86.764 | -27.670 | -11.240 | 17.580 |
Wednesday, October 15, 2025 01:18 AM
Alvotech’s biosimilar strategy, strong partnerships, and global launches may offer compelling biotech investment potential in 2024-2026. See more on ALVO here.
|
Monday, October 06, 2025 01:39 AM
Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe and Alvotech ...
|
Wednesday, September 24, 2025 12:42 AM
Alvotech ALVO shares rallied 8.6% in the last trading session to close at $8.7. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
21/10/25 | 8.52 | 8.53 | 8.35 | 8.52 | 243,599 |
20/10/25 | 8.72 | 8.745 | 8.575 | 8.59 | 245,619 |
17/10/25 | 8.58 | 8.73 | 8.43 | 8.72 | 314,433 |
16/10/25 | 8.99 | 9.00 | 8.645 | 8.75 | 300,883 |
15/10/25 | 8.75 | 9.045 | 8.70 | 8.98 | 512,366 |
14/10/25 | 8.30 | 8.59 | 8.2445 | 8.50 | 638,843 |
13/10/25 | 8.33 | 8.347 | 7.97 | 7.97 | 290,012 |
10/10/25 | 8.30 | 8.30 | 7.97 | 8.24 | 422,433 |
09/10/25 | 8.76 | 8.82 | 8.265 | 8.30 | 365,809 |
08/10/25 | 8.825 | 8.96 | 8.66 | 8.68 | 273,526 |
|
|
||||
|
|
||||
|
|